Purchase Order 75N90024P00094
Award Date 12/7/23
Potential Completion Date 12/29/23
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Germany
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency under the U.S. Department of Health and Human Services, to Sirion Biotech GmbH, a foreign-owned for-profit organization. The $21,966.56 contract provides LENTIBOOST formulated, Good Manufacturing Practice (GMP)-grade lentiviral products and other viral vector reagents from Sirion Biotech's facilities in Germany. These specialized reagents support gene therapy research...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center awarded a firm-fixed-price purchase order to Sirion Biotech GMBH, a foreign-owned for-profit company, for the delivery of LENTIBOOST formulated, good manufacturing practice (GMP)-grade lentiviral products. The $21,000 contract is to support gene therapy research and patient treatments conducted by the NIH Clinical Center. The award does not include any set-aside designation or subcontractors....
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm-fixed price purchase order to Sirion Biotech GmbH, a foreign-owned for-profit organization, for the delivery of LENTIBOOST formulated, GMP-grade viral vector products. The order, valued at $21,000.00, supported gene therapy research and patient treatments conducted by the NIH Clinical Center. The contract did not have any set-aside designations and Sirion Biotech delivered the requested viral...
- This is a $139,310.40 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Revvity Health Sciences, Inc., a subsidiary of Revvity Inc. The contract is for the delivery of 6066769 BRITELITE PLUS 100 ML KIT medical imaging products. It does not have a small business set-aside designation. Revvity Health Sciences, Inc. is a for-profit manufacturer of medical imaging and laboratory...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $29,645.10 firm fixed price purchase order to Biolegend, Inc. for BIOLEGEND REAGENTS. Biolegend, Inc. is a subsidiary of Revvity Inc. Medical Imaging, LLC. The place of performance will be Biolegend's facilities located in San Diego, California. The period of performance is from June 27, 2023 through September 30, 2023. No additional details were provided regarding subcontractors or the NIH...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $15,363 delivery order to Illumina, Inc. to provide reagents needed by the Department of Laboratory Medicine. The firm fixed price order is for the delivery of laboratory reagents to support the work of the Department of Laboratory Medicine at the NIH Clinical Center in San Diego, California. The period of performance is from July 27, 2023 through August 26, 2023. No major subcontractors or set...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $13,670.60 firm-fixed-price purchase order to Revvity Health Sciences, Inc. for the STEADYLITE PLUS 1000ML KIT. The contract, which does not have a set-aside designation, was awarded on August 1, 2019 with a completion date of August 23, 2019. Revvity Health Sciences, Inc. is a for-profit manufacturer that provides medical imaging products and services to...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $30,672 purchase order to Takara Bio Usa, Inc. for the delivery of RETRONECTIN GMP GRADE REAGENT. Performance will take place in San Jose, California over a period of approximately two months from December 2023 through February 2024. As the prime contractor, Takara Bio Usa, Inc. will provide the requested biomedical products to support the NIH Clinical Center's medical research efforts. No...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Purchase Order to Revvity Health Sciences, Inc. for a GENE ASSAY SYSTEM 1000ML with a potential value of $13,959.00. The contract has a completion date of September 28, 2018. Revvity Health Sciences, Inc. is a for-profit manufacturer of medical imaging products and services that has received numerous prime contracts and subcontracts from...
- The National Institutes of Health Clinical Center awarded a $11,499.75 firm fixed price purchase order to Miltenyi Biotec, Inc. of Auburn, California for CLINIMACS CD62L GMP microbeads. The purchase order is funded by the Department of Health and Human Services and supports the NIH Clinical Center's medical research programs. No subcontractors or set aside designations were identified. The single award purchase order is for the delivery of clinical grade microbeads between August 1, 2023 and...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $10,970 purchase order to Sirion Biotech GMBH for LENTIBOOST formulated, GMP-grade products. Sirion Biotech GMBH, a division of Revvity Inc. Medical Imaging, LLC, will deliver the requested products from its facilities in Germany by December 29, 2023. The award was made utilizing firm-fixed pricing. No subcontractors or set-aside designations were indicated. The National Institutes of Health Clinical Center supports the NIH's intramural research program and regularly procures specialized medical products and technologies to advance treatment of complex medical conditions.
Generated 12/19/23, 5:26 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 12/6/23 |